These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serum and urinary fibrin-fibrinogen degradation products in renal disease. Cash JD; Clarkson AR Scand J Haematol Suppl; 1971; 13():331-6. PubMed ID: 4945834 [No Abstract] [Full Text] [Related]
3. Fibrinogen degradation products (F.D.P.) in renal disease: estimation and significance of F.D.P. in urine. McNicol GP; Prentice CR; Briggs JD; Pidgeon C Scand J Haematol Suppl; 1971; 13():329-30. PubMed ID: 5290694 [No Abstract] [Full Text] [Related]
4. The determination of fibrinolytic degradation products in concentrated urine after renal transplantation. Ekberg M; Bergentz SE; Hedner U; Nilsson IM Scand J Urol Nephrol; 1976; 10(1):56-62. PubMed ID: 775625 [TBL] [Abstract][Full Text] [Related]
5. Significance of fibrin split products in patients with renal failure. Haanen C; Nováková I; Wijdeveld P; van Liebergen F Scand J Haematol Suppl; 1971; 13():345-50. PubMed ID: 4945835 [No Abstract] [Full Text] [Related]
6. [Fibrin degradation products in the urine in renal diseases]. Iversen BM; Ofstad J; Thunold S; Willassen Y Tidsskr Nor Laegeforen; 1976 Jan; 96(2):91-3. PubMed ID: 766292 [No Abstract] [Full Text] [Related]
7. Determination of fibrinogen degradation products in serum and urine as a new diagnostic tool. Nilsson IM Scand J Haematol Suppl; 1971; 13():317-22. PubMed ID: 4945833 [No Abstract] [Full Text] [Related]
8. Urine fibrinogen fragments in human renal allografts. A possible mechanism of renal injury. Braun WE; Merrill JP N Engl J Med; 1968 Jun; 278(25):1366-71. PubMed ID: 4231285 [No Abstract] [Full Text] [Related]
9. [Fibrinogen degradation products in the urine after kidney transplantation]. Grob PJ; Thöni R; Scheitlin W Schweiz Med Wochenschr; 1971 Jun; 101(24):873-7. PubMed ID: 4947022 [No Abstract] [Full Text] [Related]
10. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation. Scott WL; Francis CW; Knutson DW; Marder VJ J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810 [TBL] [Abstract][Full Text] [Related]
11. Urinary fibrin-fibrinogen degradation products (FDP) in renal diseases and during thrombolytic therapy. Hedner U Scand J Clin Lab Invest; 1973 Oct; 32(2):175-82. PubMed ID: 4588514 [No Abstract] [Full Text] [Related]
12. Radio-fibrinogen catabolism and fibrin products for the assessment of renal disease. Wardle EN Nephron; 1977; 18(4):193-200. PubMed ID: 323738 [TBL] [Abstract][Full Text] [Related]
13. Early Posttransplant Tryptophan Metabolism Predicts Long-term Outcome of Human Kidney Transplantation. Vavrincova-Yaghi D; Seelen MA; Kema IP; Deelman LE; van der Heuvel MC; Breukelman H; Van den Eynde BJ; Henning RH; van Goor H; Sandovici M Transplantation; 2015 Aug; 99(8):e97-104. PubMed ID: 25651307 [TBL] [Abstract][Full Text] [Related]
18. [Estimation of the glomerular filtration rate from the serum creatinine]. Heierli C; Thölen H; Bartels H Dtsch Med Wochenschr; 1972 Jan; 97(3):67-70. PubMed ID: 4550209 [No Abstract] [Full Text] [Related]
19. Aggregation of red cells and plasma viscosity in renal patients treated by haemodialysis or kidney graft effect of proteins and ABO blood groups. Dintenfass L; Stewart JH Microvasc Res; 1974 May; 7(3):342-50. PubMed ID: 4597788 [No Abstract] [Full Text] [Related]
20. Urinary fibrinogen and fibrin fragments in children with renal disease. Yoshioka K; Iseki T; Akano N; Uraoka Y; Miyata H; Maki S Nephron; 1982; 32(2):135-9. PubMed ID: 7177290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]